About this Research Topic
Epilepsy is a highly prevalent neurological disorder. Currently, there are approximately 65 million people of all ages are suffered from epilepsy worldwide, especially in developing countries. The common phenomena of epilepsy are bodily distortion and loss of consciousness, such symptoms increase the risk of injury, hospitalization, and mortality in patients with epilepsy. The occurrence of seizures is unpredictable and it has a great impact on the patients’ life quality and mental health. The pathogenesis of epilepsy is complex and varied, and treatment may last a long time, even a lifetime, which imposes a high healthcare burden on society.
Psychiatric comorbidities, such as anxiety and depression, are extremely common in patients with epilepsy (PWE), often occurring at rates 2-3-fold or higher than in the general population without epilepsy. Anxiety and depression in PWE often lead to an inadequate response to treatment and then negatively influence the course of epilepsy, such as reducing life quality, increasing the risk of refractory epilepsy, and enhancing mortality. However, the risk of these comorbidities is often underestimated. Now, the control of seizures is usually the primary goal in the management of epilepsy. The recognition and treatment of comorbidities in PWE are often insufficient due to lacking effective diagnostic methods and treatment strategies for these psychiatric comorbidities. Therefore, further research is urgently needed to enhance our understanding of epilepsy and its comorbidities, improve our ability to diagnose and treat epileptic comorbidities and improve the prognosis and life quality of PWE.
This Research Topic is devoted to collect valuable knowledge about anxiety and depression disorder in PWE from diagnosis to treatment. The themes of interest include but are not limited to:
- Developing novel methods for early detection and diagnose of anxiety and depression disorder in PWE
- Exploring standardized treatment strategies of anxiety and depression disorder in PWE
- Investigating individualized prevention and treatment strategies of anxiety and depression disorder in PWE.
Psychiatric comorbidities, such as anxiety and depression, are extremely common in patients with epilepsy (PWE), often occurring at rates 2-3-fold or higher than in the general population without epilepsy. Anxiety and depression in PWE often lead to an inadequate response to treatment and then negatively influence the course of epilepsy, such as reducing life quality, increasing the risk of refractory epilepsy, and enhancing mortality. However, the risk of these comorbidities is often underestimated. Now, the control of seizures is usually the primary goal in the management of epilepsy. The recognition and treatment of comorbidities in PWE are often insufficient due to lacking effective diagnostic methods and treatment strategies for these psychiatric comorbidities. Therefore, further research is urgently needed to enhance our understanding of epilepsy and its comorbidities, improve our ability to diagnose and treat epileptic comorbidities and improve the prognosis and life quality of PWE.
This Research Topic is devoted to collect valuable knowledge about anxiety and depression disorder in PWE from diagnosis to treatment. The themes of interest include but are not limited to:
- Developing novel methods for early detection and diagnose of anxiety and depression disorder in PWE
- Exploring standardized treatment strategies of anxiety and depression disorder in PWE
- Investigating individualized prevention and treatment strategies of anxiety and depression disorder in PWE.
Keywords: Epilepsy, Anxiety, Depression, Diagnosis, Prevention, Treatment
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
